CASIF · CASI Pharmaceuticals, Inc.
Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
|
2026-07-31
Scheduled
FINRA publishes Aug 11
|
— | — | — | — |
| 2026-07-15 | 144,504 | 144,504 | 0 | 18.20 |
| 2026-06-30 | 144,504 | 283,470 | -138,966 | 16.78 |
| 2026-06-15 | 283,470 | 305,345 | -21,875 | 5.27 |
| 2026-05-29 | 305,345 | 314,130 | -8,785 | 37.40 |
| 2026-05-15 | 314,130 | 318,519 | -4,389 | 16.26 |
| 2026-04-30 | 318,519 | 440,780 | -122,261 | 5.08 |
| 2026-04-15 | 440,780 | 442,451 | -1,671 | 43.38 |
| 2026-03-31 | 442,451 | 457,989 | -15,538 | 29.02 |
| 2026-03-13 | 457,989 | 450,645 | +7,344 | 4.79 |
| 2026-02-27 | 450,645 | 90,948 | +359,697 | 1.00 |